Prot #SOM230-RECAG-CL-0576: A Double-Blind Randomized Placebo-Controlled Dose-Finding Phase II Study to Assess the Efficacy and Safety of Pasireotide S.C. in Patients with Post-Bariatric Hypoglycaemia

Project: Research project

Project Details

StatusActive
Effective start/end date6/4/24 → 6/4/27

Funding

  • Medpace Clinical Research LLC (Prot #SOM230-RECAG-CL-0576 // Prot #SOM230-RECAG-CL-0576)
  • Recordati AG (Prot #SOM230-RECAG-CL-0576 // Prot #SOM230-RECAG-CL-0576)